BENZAMYCIN® Topical Gel contains erythromycin [(3R*, 4S*, 5S*, 6R*, 7R*, 9R*, 11R*, 12R*, 13S*, 14R*)-4-[(2,6-Dideoxy-3- C -methyl-3- O -methyl-α-L- ribo -hexopyranosyl)-oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D- xylo -hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione]. Erythromycin is a macrolide antibiotic produced from a strain of Saccharopolyspora erythraea (formerly Streptomyces erythreus). It is a base and readily forms salts with acids.
BENZAMYCIN Topical Gel is indicated for the topical treatment of acne vulgaris.
Media Articles Related to Benzamycin (Erythromycin / Benzoyl Peroxide Topical)
Canadian Dermatologists Issue New Acne Treatment Guidelines
Source: Medscape Dermatology Headlines [2015.11.18]
Canadian researchers have published evidence-based guidelines to aid in treating acne, which affects up to 85% of adolescents and young adults.
Reuters Health Information
New guideline for treating acne in children and adults
Source: Anxiety / Stress News From Medical News Today [2015.11.17]
A new guideline aims to help Canadian physicians, nurses and pharmacists treat children and adults with acne, a disease that can severely affect quality of life.
Source: MedicineNet Boils Specialty [2015.11.13]
Title: Acne (Pimples)
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 11/13/2015 12:00:00 AM
Acne: what causes it and how to relieve it
Source: Dermatology News From Medical News Today [2015.11.05]
Acne troubles many people, especially adolescents. The effects are physical and psychological, but treatment can alleviate even the most severe cases.
Many Patients With Acne Take Antibiotics Too Long: Study
Source: MedicineNet Acne Specialty [2015.10.30]
Title: Many Patients With Acne Take Antibiotics Too Long: Study
Category: Health News
Created: 10/30/2015 12:00:00 AM
Last Editorial Review: 10/30/2015 12:00:00 AM
Clinical Trials Related to Benzamycin (Erythromycin / Benzoyl Peroxide Topical)
Patients Response to Early Switch To Oral:Osteomyelitis Study [Not yet recruiting]
Based on the current literature, investigators hypothesize that patients with osteomyelitis
who are treated with the standard approach of intravenous antibiotics for the full duration
of therapy will have the same clinical outcomes as patients treated with the experimental
approach of intravenous antibiotics with early switch to oral antibiotics.
The primary objective of this study is to compare patients with osteomyelitis treated with
the standard approach of intravenous antibiotics for the full duration of therapy versus
patients treated with intravenous antibiotics with an early switch to oral antibiotics in
relation to clinical outcomes at 12 months after discontinuation of antibiotic therapy.
Secondary objectives of the study include the evaluation of adverse events related to the
use of antibiotics as well as the cost of care evaluated from the hospital perspective.
Page last updated: 2015-11-18